Patents by Inventor Aws Abdul-Wahid

Aws Abdul-Wahid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-domain of carcinoembryonic antigen and compositions, methods and uses thereof
    Patent number: 9636387
    Abstract: The present disclosure provides immunogenic compositions comprising the N-domain of carcinoembryonic antigen (CEA). These compositions are useful for inducing or enhancing an immune response, for inhibiting tumor cell growth and for treating cancer.
    Type: Grant
    Filed: August 18, 2014
    Date of Patent: May 2, 2017
    Assignee: Governing Council of the University of Toronto
    Inventors: Aws Abdul-Wahid, Jean Gariépy
  • N-DOMAIN OF CARCINOEMBRYONIC ANTIGEN AND COMPOSITIONS, METHODS AND USES THEREOF
    Publication number: 20150044218
    Abstract: The present disclosure provides immunogenic compositions comprising the N-domain of carcinoembryonic antigen (CEA). These compositions are useful for inducing or enhancing an immune response, for inhibiting tumor cell growth and for treating cancer.
    Type: Application
    Filed: August 18, 2014
    Publication date: February 12, 2015
    Inventors: Aws Abdul-Wahid, Jean Gariépy
  • N-domain of carcinoembryonic antigen and compositions, methods and uses thereof
    Patent number: 8846050
    Abstract: The present disclosure provides immunogenic compositions comprising the N-domain of carcinoembryonic antigen (CEA). These compositions are useful for inducing or enhancing an immune response, for inhibiting tumor cell growth and for treating cancer.
    Type: Grant
    Filed: May 11, 2011
    Date of Patent: September 30, 2014
    Assignee: Governing Council of the University of Toronto
    Inventors: Aws Abdul-Wahid, Jean Gariépy
  • N-DOMAIN OF CARCINOEMBRYONIC ANTIGEN AND COMPOSITIONS, METHODS AND USES THEREOF
    Publication number: 20130071417
    Abstract: The present disclosure provides immunogenic compositions comprising the N-domain of carcinoembryonic antigen (CEA). These compositions are useful for inducing or enhancing an immune response, for inhibiting tumor cell growth and for treating cancer.
    Type: Application
    Filed: May 11, 2011
    Publication date: March 21, 2013
    Applicant: GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO
    Inventors: Aws Abdul-Wahid, Jean Gariépy